|
THUMPD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33146835171283E-15 |
| Normal-vs-Stage2 |
4.48570000033399E-07 |
| Normal-vs-Stage3 |
9.21374088136417E-13 |
| Normal-vs-Stage4 |
2.25686136445802E-12 |
| Stage1-vs-Stage2 |
4.894800E-01 |
| Stage1-vs-Stage3 |
3.009000E-01 |
| Stage1-vs-Stage4 |
4.590500E-02 |
| Stage2-vs-Stage3 |
2.209200E-01 |
| Stage2-vs-Stage4 |
4.594200E-02 |
| Stage3-vs-Stage4 |
3.037200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.573900E-04 |
| Normal-vs-Asian |
3.96110000355776E-09 |
| Caucasian-vs-AfricanAmerican |
9.332000E-02 |
| Caucasian-vs-Asian |
4.377200E-01 |
| AfricanAmerican-vs-Asian |
3.808400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.27713461607027E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
5.594200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63424829224823E-12 |
| Normal-vs-Age(41-60Yrs) |
1.38888900380607E-13 |
| Normal-vs-Age(61-80Yrs) |
3.76160214088372E-11 |
| Normal-vs-Age(81-100Yrs) |
1.537120E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.912000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.680200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.498000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.796400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.515800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.107200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.983400E-04 |
| Classical-VS-Follicular |
4.032400E-01 |
| Classical-VS-Other |
5.253200E-01 |
| Classical-VS-Normal |
1.62592161956354E-12 |
| Tall-VS-Follicular |
5.795100E-04 |
| Tall-VS-Other |
3.236400E-01 |
| Tall-VS-Normal |
3.19744231092045E-14 |
| Follicular-VS-Other |
4.468800E-01 |
| Follicular-VS-Normal |
1.58430000007925E-07 |
| Other-VS-Normal |
9.813400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.93989269092754E-12 |
| Normal-vs-N1 |
2.94209101525666E-13 |
| N0-vs-N1 |
3.392300E-02 |
|
|
